The importance of mucormycosis infections on example of Rhino Orbital Cerebral Mucormycosis
By:
References
- Abu El-Naaj I., Leiser Y., Wolff A., Peled M.: The surgical management of rhinocerebral mucormycosis. J. Craniomaxillofac. Surg., 2013; 41: 291–295
- Amaro T.A., Yazigi L., Erwenne C.: Depression and quality of life during treatment of ocular bulb removal in individuals with uveal melanoma. Eur. J. Cancer Care, 2010; 19: 476–481
- Ambrosioni J., Bouchuiguir-Wafa K., Garbino J.: Emerging invasive zygomycosis in a tertiary care center: Epidemiology and associated risk factors. Int. J. Infect. Dis., 2010; 14: e100–e103
- Arani R., Shareef S.N., Khanam H.M.: Mucormycotic osteomyelitis involving the maxilla: A rare case report and review of the literature. Case Rep. Infect. Dis., 2019; 2019: 8459296
- Aras M.H., Kara M.I., Erkiliç S., Ay S.: Mandibular mucormycosis in immunocompromised patients: Report of 2 cases and review of the literature. J. Oral Maxillofac. Surg., 2012; 70: 1362–1368
- Artis W.M., Fountain J.A., Delcher H.K., Jones H.E.: A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability. Diabetes, 1982; 31: 1109–1114
- Bailly C., Waring M.J.: Pharmacological effectors of GRP78 chaperone in cancers. Biochem. Pharmacol., 2019; 163: 269–278
- Baldin C., Ibrahim A.S.: Molecular mechanisms of mucormycosis – The bitter and the sweet. PLoS Pathog., 2017; 13: e1006408
- Baldin C., Soliman S.S.M., Jeon H.H., Alkhazraji S., Gebremariam T., Gu Y., Bruno V.M., Cornely O.A., Leather H.L., Sugrue M.W., Wingard J.R., Stevens D.A., Edwards J.E. Jr., Ibrahim A.S.: PCR-based approach targeting mucorales-specific gene family for diagnosis of mucormycosis. J. Clin. Microbiol., 2018; 56: e00746–18
- Bernal-Martínez L., Buitrago M.J., Castelli M.V., Rodriguez-Tudela J.L., Cuenca-Estrella M.: Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. Clin. Microbiol. Infect., 2013; 19: E1–E7
- Bhatnagar A., Agarwal A.: Naso-orbital fistula and socket reconstruction with radial artery forearm flap following orbital mucormycosis. Natl. J. Maxillofac. Surg., 2016; 7: 197–200
- Bitar D., Van Cauteren D., Lanternier F., Dannaoui E., Che D., Dromer F., Desenclos J.C., Lortholary O.: Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg. Infect. Dis., 2009; 15: 1395–1401
- Bongomin F., Gago S., Oladele R.O., Denning D.W.: Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi, 2017; 3: 57
- Borle R.M.: Textbook of oral and maxillofacial surgery. Jaypee Brothers Medical Publishers, New Delhi 2014
- Burnham-Marusich A.R., Hubbard B., Kvam A.J., Gates-Hollingsworth M., Green H.R., Soukup E., Limper A.H., Kozel T.R.: Conservation of mannan synthesis in fungi of the Zygomycota and Ascomycota reveals a broad diagnostic target. mSphere, 2018; 3: e00094–18
- Chakrabarti A., Dhaliwal M.: Epidemiology of mucormycosis in India. Curr. Fungal Infect. Rep., 2013; 7: 287–292
- Chakrabarti A., Kaur H., Savio J., Rudramurthy S.M., Patel A., Shastri P., Pamidimukkala U., Karthik R., Bhattacharya S., Kindo A.J., Bhattacharya P., Todi S., Gopalakrishan R., Singh P., Pandey A., Agarwal R.: Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study). J. Crit. Care, 2019; 51: 64–70
- Chakrabarti A., Singh R.: Mucormycosis in India: Unique features. Mycoses. 2014; 57: 85–90
- Chikley A., Ben-Ami R., Kontoyiannis D.P.: Mucormycosis of the central nervous system. J. Fungi, 2019; 5: 59
- Cornely O.A., Alastruey-Izquierdo A., Arenz D., Chen S.C.A., Dannaoui E., Hochhegger B., Hoenigl M., Jensen H.E., Lagrou K., Lewis R.E., Mellinghoff S.C., Mer M., Pana Z.D., Seidel D., Sheppard D.C., et al.: Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect. Dis., 2019; 19: e405–e421
- Davoudi S., Kumar V.A., Jiang Y., Kupferman M., Kontoyiannis D.P.: Invasive mould sinusitis in patients with haematological malignancies: A 10 year single-centre study. J. Antimicrob. Chemother., 2015; 70: 2899–2905
- Dökmetaş H.S., Canbay E., Yilmaz S., Elaldi N., Topalkara A., Oztoprak I., Yildiz E.: Diabetic ketoacidosis and rhino-orbital mucormycosis. Diabetes Res. Clin. Pract., 2002; 57: 139–142
- Galletti B., Freni F., Meduri A., Oliverio G.W., Signorino G.A., Perroni P., Galletti C., Aragona P., Galletti F.: Rhino-orbito-cerebral mucormycosis in diabetic disease. J. Craniofac. Surg., 2020; 31: e321–e324
- Gebremariam T., Liu M., Luo G., Bruno V., Phan Q.T., Waring A.J., Edwards J.E. Jr., Filler S.G., Yeaman M.R., Ibrahim A.S.: CotH3 mediates fungal invasion of host cells during mucormycosis. J. Clin. Invest., 2014; 124: 237–250
- Gillespie M.B., O’Malley B.W. Jr., Francis H.W.: An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host. Arch. Otolaryngol. Head Neck Surg., 1998; 124: 520–526
- Gosavi D.K.: Acute necrosis of the maxilla due to mucormycosis. J. Laryngol. Otol., 1978; 92: 365–369
- Guinea J., Escribano P., Vena A., Muñoz P., Martínez-Jiménez M.D.C., Padilla B., Bouza E.: Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. PLoS One, 2017; 12: e0179136
- Herbrecht R., Sabou M., Ledoux M.P.: Aspects cliniques et radiologiques des mucormycoses. Med. Sci., 2013; 29: 19–24
- Ibrahim I.M., Abdelmalek D.H., Elfiky A.A.: GRP78: A cell’s response to stress. Life Sci., 2019; 226: 156–163
- Ilharco M., Pereira C.M., Moreira L., Proença A.L., do Carmo Fevereiro M., Lampreia F., Oliveira M.L., Rola J.: Rhinoorbital mucormycosis in the immunocompetent: Experience with isavuconazole. ID Cases, 2019; 18: e00591
- Inbarajan A., Natarajan S., Thirumalai Thangarajan S., Seenivasan M., Banu F., Anand Kumar V.: Impact of prosthodontic treatment on the oral health-related quality of life in mucormycosis patient: A case report. Cureus, 2018; 10: e3493
- Jeong W., Keighley C., Wolfe R., Lee W.L., Slavin M.A., Kong D.C., Chen S.C.: The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports. Clin. Microbiol. Infect., 2019; 25: 26–34
- Kasapoglu F., Coskun H., Ozmen O.A., Akalin H., Ener B.: Acute invasive fungal rhinosinusitis: Evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol. Head Neck Surg., 2010; 143: 614–620
- Koehler P., Mellinghoff S.C., Lagrou K., Alanio A., Arenz D., Hoenigl M., Koehler F.C., Lass-Flörl C., Meis J.F., Richardson M., Cornely O.A.: Development and validation of the European QUAL-ity (EQUAL) score for mucormycosis management in haematology. J. Antimicrob. Chemother., 2019; 74: 1704–1712
- Kornblith A.B., Zlotolow I.M., Gooen J., Huryn J.M., Lerner T., Strong E.W., Shah J.P., Spiro R.H., Holland J.C.: Quality of life of maxillectomy patients using an obturator prosthesis. Head Neck, 1996; 18: 323–334
- Li J., Nguyen C.T., Garcia-Diaz J.: Role of new antifungal agents in the treatment of invasive fungal infections in transplant recipients: Isavuconazole and new posaconazole formulations. J. Fungi, 2015; 1: 345–366
- Manfredi M., Polonelli L., Giovati L., Alnuaimi A., McCullough M.J.: Oral and Maxillofacial Fungal Infections. In: Contemporary Oral Medicine. A Comprehensive Approach to Clinical Practice, eds.: C.S. Farah, R. Balasubramaniam, M.J. McCullough. Springer International Publishing, Cham 2018, 935–981
- Mani U.M., Mohamed K., Krishna Kumar A., Inbarajan A.: A modified technique to fabricate a complete hollow obturator for bilateral maxillectomy in a patient with mucormycosis – A technical case report. Spec. Care Dentist., 2019; 39: 610–616
- Mathebula S.D.: Mucormycosis. African Vision and Eye Health. 2008; 67, 36–41
- Mercier T., Reynders M., Beuselinck K., Guldentops E., Maertens J., Lagrou K.: Serial detection of circulating mucorales DNA in invasive mucormycosis: A retrospective multicenter evaluation. J. Fungi, 2019; 5: 113
- Millon L., Scherer E., Rocchi S., Bellanger A.P.: Molecular strategies to diagnose mucormycosis. J. Fungi, 2019; 5: 24
- Navarro-Perea C, Cañas-Zamarra I, Mencía-Gutiérrez E., Revilla-Sánchez E., Lago-Llinás M.D., Pérez-Trigo S., Bengoa-González Á.: Rhino-orbito-cerebral mucormycosis: Two cases with amaurosis as presentation, medical surgical management and follow-up. Case Rep. Ophthalmol Med., 2019; 2019: 4215989
- Ogawa T., Takezawa K., Tojima I., Shibayama M., Kouzaki H., Ishida M., Okabe H., Shimizu T.: Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin. Auris Nasus Larynx., 2012; 39: 224–228
- Oh W.S., Roumanas E.: Dental implant-assisted prosthetic rehabilitation of a patient with a bilateral maxillectomy defect secondary to mucormycosis. J. Prosthet. Dent., 2006; 96: 88–95
- Paltauf A.: Mycosis mucorina. Archiv F. Pathol. Anat., 1885; 102: 543–564
- Prakash H., Chakrabarti A.: Global epidemiology of mucormycosis. J. Fungi, 2019; 5: 26
- Prakash H., Ghosh A.K., Rudramurthy S.M., Singh P., Xess I., Savio.J, Pamidimukkala U., Jillwin J., Varma S., Das A., Panda N.K., Singh S., Bal A., Chakrabarti A.: A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med. Mycol., 2019; 57: 395–402
- Ramadorai A., Ravi P., Narayanan V.: Rhinocerebral mucormycosis: A prospective analysis of an effective treatment protocol. Ann. Maxillofac. Surg., 2019; 9: 192–196
- Saegeman V., Maertens J., Meersseman W., Spriet I., Verbeken E., Lagrou K.: Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg. Infect. Dis., 2010; 16: 1456–1458
- Schwarz P., Guedouar H., Laouiti F., Grenouillet F., Dannaoui E.: Identification of mucorales by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J. Fungi, 2019; 5: 56
- Serris A., Danion F., Lanternier F.: Disease entities in mucormycosis. J. Fungi, 2019; 5: 23
- Spellberg B., Edwards J. Jr., Ibrahim A.: Novel perspectives on mucormycosis: Pathophysiology, presentation, and management. Clin. Microbiol. Rev., 2005; 18: 556–569
- Trifilio S., Singhal S., Williams S., Frankfurt O., Gordon L., Evens A., Winter J., Tallman M., Pi J., Mehta J.: Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant., 2007; 40: 451–456
- Turner J.H., Soudry E., Nayak J.V., Hwang P.H.: Survival outcomes in acute invasive fungal sinusitis: A systematic review and quantitative synthesis of published evidence. Laryngoscope, 2013; 123: 1112–1118
- Walsh T.J., Hospenthal D.R., Petraitis V., Kontoyiannis D.P.: Necrotizing mucormycosis of wounds following combat injuries, natural disasters, burns, and other trauma. J. Fungi, 2019; 5: 57
- Walther G., Wagner L., Kurzai O.: Updates on the taxonomy of mucorales with an emphasis on clinically important taxa. J. Fungi, 2019; 5: 106
- Zuniga M.G., Turner J.H.: Treatment outcomes in acute invasive fungal rhinosinusitis. Curr. Opin. Otolaryngol. Head Neck Surg., 2014; 22: 242–248
DOI: https://doi.org/10.5604/01.3001.0014.8123 | Journal eISSN: 1732-2693
Language: English
Page range: 211 - 216
Submitted on: May 13, 2020
Accepted on: Oct 12, 2020
Published on: Mar 18, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2021 Łukasz Pałka, Vivek Gaur, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.